Apr 14, 20211 min
$MRNA +6.9% Announces clinical progress from leading mRNA vaccine. source
$LUMO +5.8% Hosting key opinion leader webinar on LUM-201 on April 27, 2021. source
$PRAX -16.7% Receives Orphan Drug Designation for PRAX-562. source
$IMAB +11% Uliledlimab selected for poster presentation at ASCO 2021. source
$AGEN -0.7% First patient dosed in agenT-797 iNKT cell therapy trial. source
$ARDX +8.9% Collaboration partner Kyowa Kirin initiated Phase 3 trial of tenapanor in Japan. source
$RCKT +3.5% Positive long-term data from RP-L201 trial reported at CIS 2021. source
$GILD +0.6% Granted accelerated approval of Trodelvy for metastatic urothelial cancer. source
$GALT +9% Phase 1 data published in Journal for ImmunoTherapy of Cancer on Belapectin. source
$AZN +1.3% Approves Tagrisso in China in early lung cancer. source